JFG
HRTX icon

Jefferies Financial Group’s Heron Therapeutics HRTX Stock Holding History

Jefferies Financial Group’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-666,800
Closed -$1.38M – 1554
2025
Q2 		$1.38M Buy
666,800
+344,200
+107% +$703K 0.01% 629
2025
Q1 		$710K Buy
+322,600
New +$626K 0.01% 942
2023
Q3 		– Sell
-1,290,924
Closed -$1.5M – 1768
2023
Q2 		$1.5M Buy
+1,290,924
New +$2.3M 0.01% 761

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jefferies Financial Group's HRTX Position: Q3 2025 in Review

Jefferies Financial Group sold out of Heron Therapeutics (HRTX) in Q3 2025, closing a stake of 666,800 shares — an estimated $1.38M sold.

Jefferies Financial Group first reported a position in HRTX in Q2 2023 and held it in 3 quarters. The position peaked at $1.5M in Q2 2023. 172 funds tracked by Wall St. Rank hold HRTX as of Q3 2025.

  • Jefferies Financial Group reported no remaining Heron Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Jefferies Financial Group sold 666,800 Heron Therapeutics shares in Q3 2025, an estimated $1.38M.
  • Jefferies Financial Group first reported a position in Heron Therapeutics in Q2 2023 and held it in 3 quarters.
  • Jefferies Financial Group's Heron Therapeutics position peaked at $1.5M in Q2 2023.
  • 172 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2025.

Based on Jefferies Financial Group's 13F filing for Q3 2025, filed 13 Nov 2025.